Professor Melanie Davies

Type 2 ‘cost effective’ drug unveiled

3rd March 2016

Xultophy (IDegLira) has been found to be more cost-effective when compared with current basal insulin intensification in people with uncontrolled type 2 diabetes. The findings of the once-daily ...

Read more

Global focus on diabetes

5th February 2016

Good practice in diabetes care and type 2 prevention from across the world was exchanged at a conference this week. More than 100 delegates with an interest in diabetes attended the International ...

Read more

Diabetes professor awarded CBE

30th December 2015

A doctor who established an international centre of excellence in diabetes research in Leicester has been awarded a CBE in the New Year’s Honours List. Professor Melanie Davies has been ...

Read more

Education call as type 2 numbers soar

17th August 2015

A leading diabetes researcher has called on health bosses to prioritise education to avoid costly complications as type 2 diabetes cases continue to rise. The number of people living with ...

Read more